Mimedx Group Inc
Company Overview
MiMedx Group, Inc. is a placental biologics company that develops and distributes placental tissue allografts for multiple sectors of healthcare. Their products are used in wound care, surgical, orthopedic, and spine applications. The company processes amniotic tissue using their proprietary PURION® process to produce a range of products that help in tissue repair and regeneration.
The company's main product lines include EpiFix®, AmnioFix®, and AMNIOFIX Injectable, which are derived from human placental tissues and processed using proprietary methods to preserve the tissue's natural properties while removing unwanted materials.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $84.06m | $72.89m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $87.21m | $63.76m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $84.71m | $73.2m | - | $1.69m | 0.00% | 2.31% |
Company Impact
Help us evaluate Mimedx Group Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.